Insights on Discovery

1. Closing The QC Gap For mAbs: Rapid Answers Without Compromising 6/9/2026

   Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

2. Get More From Less: AMP Chemistry Outperforms Hybrid Capture 6/9/2026

   Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.

3. Direct qPCR Amplification From Human Urine Samples 6/9/2026

   Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.

4. Direct Amplification Of Samples Associated With Strawberry Leaf Punches 6/9/2026

   Skip extraction and still achieve reliable qPCR results. See how direct amplification of plant samples enables faster workflows, lower costs, and clear detection of resistance markers.

5. Designing RNase H1 "Gapmer" Antisense Oligonucleotides 6/9/2026

   Effective RNA-targeting oligonucleotide design hinges on balancing affinity, stability, and selectivity. Explore how chemical modifications, sequence choices, and delivery approaches influence potency.

6. Comprehensive And Streamlined Genomic Signature Assessment 6/9/2026

   Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.

7. T Cells In Immunotherapies: The Key Progress Underway 6/1/2026

   CAR-T therapies now make up 73% of active pipeline programs, yet solid tumors remain largely out of reach. Where is T cell immunotherapy headed next, and what does it mean for your pipeline strategy?

8. Materials Matter: Reframing Raw Material Strategy In Cell And Gene Therapy Development 5/1/2026

   Scaling iPSC-based therapies from lab to CGMP manufacturing demands tightly controlled cryopreservation, risk-based QC, and strategic automation to preserve cell viability, consistency, and regulatory readiness.

9. Sensitive Viral Safety Testing For Adventitious Virus Detection 4/20/2026

   Discover a modern approach to adventitious virus detection that shows how targeted sequencing can achieve sensitive, comprehensive viral safety testing aligned with ICH MAP, RAP, and HAP expectations.

10. Direct Cell Lysis Enables Rapid And Robust Vector Copy Number (VCN) Quantification Using QIAcuity Digital PCR 4/20/2026

    Explore a faster approach to vector copy number measurement that replaces DNA extraction with direct cell lysis and digital PCR, delivering accurate, reproducible results across fresh and frozen samples.